Showing 1 - 1 of 1
In this study, we analyze the impact of pharmaceutical companies' CSR (corporate social responsibility) activities on doctors' decisions about prescription drugs in a qualitative approach. In Japan, the decision-makers of prescription drugs are not patients who actually use the drugs but...
Persistent link: https://www.econbiz.de/10011105524